Skip to main content
logo
Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.4500
0.00 (0.00%)
Jul 28, 2026, 4:00 PM EDT - Market closed

Pasithea Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-----0.02
Revenue Growth
------
Gross Profit
------0
Operating Income
-22.05-20.86-14.25-15.98-12.59-4.51
Net Income
-19.73-20.43-13.9-15.96-13.94-2.17
Earnings Per Share
-2.08-2.91-12.69-12.64-9.29-4.20
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
50.555.266.9216.3333.0952.97
Total Debt
0000.080.50
Net Cash (Debt)
50.555.266.9216.2532.5852.97
Net Cash Growth
845.49%698.24%-57.40%-50.13%-38.48%-
Net Cash Per Share
4.027.866.3213.2525.81101.81

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-16.94-15.21-13.92-12.81-11.89-3.17
Capital Expenditures
----0.03-0.11-0.02
Free Cash Flow
-16.94-15.21-13.92-12.85-12-3.2
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------14.69%
Operating Margin
------29925.70%
Pretax Margin
------14430.49%
Profit Margin
------14430.50%
FCF Margin
------21216.00%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-----2703.81